ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Consequently, adiponectin deficiency has been linked to an increased risk of metabolic syndrome components, including obesity, type 2 diabetes mellitus, hypertension, and cardiovascular diseases [40,43,44].